Itamar Medical Ltd (ITMR)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Itamar Medical Ltd (ITMR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014297
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Itamar Medical Ltd (Itamar Medical) is a medical device company that offers bio-medical technology products. The company develops, markets and distributes diagnostic medical devices. Its products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction; and WatchPAT, a diagnostic device which provides accurate screening, detection, and diagnosis of sleep apnea and sleep disorders. Itamar Medical conducts research and development of non-invasive medical equipment for diagnosis of several medical conditions such as cardiovascular disease and respiratory disorders. The company’s products find application in research centers, clinical institutions and pharmaceutical clinical phase studies. Itamar Medical is headquartered in Caesarea, Israel.

Itamar Medical Ltd (ITMR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Itamar Medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Itamar Medical Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Viola Private Equity to Invest USD24 Million in Itamar Medical 11
Equity Offering 12
Itamar Medical Plans to Raise USD6 Million in Rights Offering of Shares 12
Itamar Medical to Raise USD24 Million in Private Placement of Shares 13
Asset Transactions 14
Galmed Pharma Acquires EndoPAT Devices from Itamar Medical for USD0.7 Million 14
Itamar Medical Ltd – Key Competitors 15
Itamar Medical Ltd – Key Employees 16
Itamar Medical Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Itamar Medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Itamar Medical Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Itamar Medical Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Viola Private Equity to Invest USD24 Million in Itamar Medical 11
Itamar Medical Plans to Raise USD6 Million in Rights Offering of Shares 12
Itamar Medical to Raise USD24 Million in Private Placement of Shares 13
Galmed Pharma Acquires EndoPAT Devices from Itamar Medical for USD0.7 Million 14
Itamar Medical Ltd, Key Competitors 15
Itamar Medical Ltd, Key Employees 16
Itamar Medical Ltd, Subsidiaries 17

★海外企業調査レポート[Itamar Medical Ltd (ITMR)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Columbus A/S (COLUM):企業の財務・戦略的SWOT分析
    Summary Columbus A/S (Columbus), formerly Columbus IT Partner A/S, is a technology company that offers integrated business systems. The company offers digital transformation, ERP and CRM solutions and Columbus solutions. Its digital transformation solution includes cloud, mobility, e-commerce and In …
  • Offshore Oil Engineering Co Ltd (600583):石油・ガス:M&Aディール及び事業提携情報
    Summary Offshore Oil Engineering Co Ltd (COOEC), a subsidiary of China National Offshore Oil Corp, is a general engineering contractor that offers offshore engineering construction services. The company’s services include engineering, procurement, construction, installation, maintenance and underwat …
  • Circuit Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Circuit Therapeutics Inc (Circuit Therapeutics) is a biotechnology company that offers discovery and development of transformational therapies. The company holds expertise in optogenetics technology. Its optogenetics allows control of specific neurons and drives their activity. Circuit Thera …
  • BNC Bancorp:企業のM&A・事業提携・投資動向
    BNC Bancorp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BNC Bancorp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • TBEA Xinjiang Sunoasis Co Ltd:電力:M&Aディール及び事業提携情報
    Summary TBEA Xinjiang Sunoasis Co Ltd (TBEA) is a renewable energy company that manufactures and markets solar energy products. The company offers products such as photovoltaic power generation systems, monocrystalline silicon wafers, polycrystalline silicon films, inverter control system, monocryst …
  • Endo International Plc (ENDP)-医療機器分野:企業M&A・提携分析
    Summary Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies including Endo Pharmaceuticals, Paladin Labs, Par Pharmaceutical, …
  • Punjab & Sind Bank:企業の戦略・SWOT・財務情報
    Punjab & Sind Bank - Strategy, SWOT and Corporate Finance Report Summary Punjab & Sind Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Akonni Biosystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company provides product such as nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray reader …
  • Egypt Gas (EGAS):企業の財務・戦略的SWOT分析
    Summary Egypt Gas (EG) is oil and gas service contractor that offers distribution of natural gas and the implementation of natural gas projects. The company offers services such as mechanical works, supply and construction of pressure reduction and measurement units, suspended and buried gas pipelin …
  • Cyprotex Ltd-医療機器分野:企業M&A・提携分析
    Summary Cyprotex Ltd (Cyprotex), a subsidiary of Evotec AG is a provider of ADME-Tox contract research services. It provides these services to the biotechnology, pharmaceutical, cosmetics/personal care and chemical industries. The company’s core capabilities include high quality mechanistic toxicolo …
  • Targovax ASA (TRVX):企業の財務・戦略的SWOT分析
    Summary Targovax ASA (Targovax) is a developer and commercializer of immunotherapies for the treatment of cancer patients. The company’s lead candidates include TG0, a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipeline …
  • Costcutter Supermarkets Group Ltd:企業の戦略・SWOT・財務分析
    Costcutter Supermarkets Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Costcutter Supermarkets Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • MolMed SpA (MLM):企業の財務・戦略的SWOT分析
    Summary MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of hi …
  • Uni-President Enterprises Corp:企業の戦略・SWOT・財務情報
    Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report Summary Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • eGain Corp (EGAN):企業の財務・戦略的SWOT分析
    Summary eGain Corp (eGain) is a technology company that provides cloud-based and on-site customer engagement software solutions. The company offers products such as eGain case manager, eGain chat, eGain clicktocall, eGain cobrowse, eGain community, eGain consulting, and eGain virtual assistant. It a …
  • Brookfield Asset Management Inc.:企業の戦略・SWOT・財務分析
    Brookfield Asset Management Inc. - Strategy, SWOT and Corporate Finance Report Summary Brookfield Asset Management Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Wotif.com Holdings Limited:企業の戦略・SWOT・財務分析
    Wotif.com Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Wotif.com Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Banque Internationale à Luxembourg SA:企業の戦略・SWOT・財務情報
    Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report Summary Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Endress+Hauser AG:企業の戦略的SWOT分析
    Endress+Hauser AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Ocean Bio-Chem Inc (OBCI):企業の財務・戦略的SWOT分析
    Summary Ocean Bio-Chem Inc (OBCI) is a chemical manufacturing company that manufactures and markets maintenance and appearance products. The company's products include star brite products, performacide products, star tron products, and odor star products, among others. Its star tron products compris …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆